Scarica l'app Stockscreener
7.24
0.14%
-0.010
Dopo l'orario di chiusura:
7.24
Precedente Chiudi:
$7.25
Aprire:
$7.16
Volume 24 ore:
143.43K
Relative Volume:
0.36
Capitalizzazione di mercato:
$199.84M
Reddito:
$45.07M
Utile/perdita netta:
$-44.49M
Rapporto P/E:
-1.9483
EPS:
-3.716
Flusso di cassa netto:
$-54.23M
1 W Prestazione:
-1.76%
1M Prestazione:
-2.95%
6M Prestazione:
+35.33%
1 anno Prestazione:
+44.51%
Intervallo 1D:
$7.035
$7.27
Intervallo di 1 settimana:
$7.035
$7.575
Portata 52W:
$3.53
$9.62
Precision Biosciences Inc Stock (DTIL) Company Profile
Nome
Precision Biosciences Inc
Settore
Industria
Telefono
919-314-5512
Indirizzo
302 EAST PETTIGREW STREET, DURHAM, NC
Compare DTIL vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DTIL
Precision Biosciences Inc
|
7.24 | 200.11M | 45.07M | -44.49M | -54.23M | -3.716 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-10 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2024-04-30 | Iniziato | Guggenheim | Buy |
| 2022-06-17 | Iniziato | BMO Capital Markets | Outperform |
| 2022-06-09 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2020-07-27 | Ripresa | BTIG Research | Buy |
| 2020-04-03 | Downgrade | Goldman | Buy → Neutral |
| 2020-03-05 | Iniziato | Stifel | Buy |
| 2020-02-25 | Iniziato | William Blair | Outperform |
| 2019-08-09 | Iniziato | BTIG Research | Buy |
| 2019-07-16 | Iniziato | H.C. Wainwright | Buy |
| 2019-04-22 | Iniziato | Barclays | Overweight |
| 2019-04-22 | Iniziato | Goldman | Buy |
| 2019-04-22 | Iniziato | JP Morgan | Overweight |
| 2019-04-22 | Iniziato | Jefferies | Buy |
Mostra tutto
Precision Biosciences Inc Borsa (DTIL) Ultime notizie
CPTx appoints Matt Kane as Chief Financial Officer - GlobeNewswire Inc.
Behavioral Patterns of DTIL and Institutional Flows - Stock Traders Daily
Precision BioSciences stock gains as market cap tops 200 million USD - ad-hoc-news.de
Precision Biosciences Stock Price Forecast. Should You Buy DTIL? - StockInvest.us
Precision BioSciences Inc. (DTIL) Key Financial Ratios – Valuation, Profitability & More - Value Research
Precision BioSciences Inc. (DTIL) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Precision BioSciences doses first patient in DMD gene editing trial By Investing.com - Investing.com Canada
Precision BioSciences Commences Dosing in Phase 1/2 FUNCTION-DMD Study - Business Wire
Precision (DTIL) Range: Posts a 2.59% Gain to $8.72 at the Close; the Current Price Sits Inside the Supplied Technical Range in the Latest ReadingLiquidity Order Flow - vinanet.vn
DTIL Looks 355.6% Overvalued on GF Value™ - GuruFocus
Precision BioSciences: Promising HBV Editing Evidence (NASDAQ:DTIL) - Seeking Alpha
Precision BioSciences Inc (DTIL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Precision BioSciences Inc Stock Intrinsic Values - GuruFocus
Precision BioSciences Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Precision BioSciences Inc (HAM:PBS0) Competitors 2026 - GuruFocus
Precision BioSciences Inc Stock Warning Signs | HAM:PBS0 - GuruFocus
Who's Buying or Selling Precision BioSciences Inc (HAM:PBS0) Stock Today? - GuruFocus
Precision BioSciences Inc (HAM:PBS0) Stock Price & 30 Year Financial Data - GuruFocus
Precision BioSciences Inc (HAM:PBS0) Stock Earnings Transcripts - GuruFocus
Precision BioSciences Inc (HAM:PBS0) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
HAM:PBS0 Dividend: Does Precision BioSciences Inc Pay a Dividend? - GuruFocus
Precision BioSciences Inc (HAM:PBS0) Stock Price, Trades & News - GuruFocus
Precision BioSciences Inc (HAM:PBS0) Stock News, Headlines & Updates - GuruFocus
Precision BioSciences (DTIL) Rises 1.78% as Gene-Editing Stock Holds Firm Above SupportGrowth Stock Picks - vinanet.vn
Precision BioSciences (DTIL) Advances 1.78% as Gene-Editing Speculation BuildsBear Flag - vinanet.vn
DTIL Q2 2026 Earnings: Wider-than-Expected Loss Highlights Clinical-Stage Biotech ChallengesGAAP Earnings Report - vinanet.vn
Analysts Have Lowered Expectations For Precision BioSciences, Inc. (NASDAQ:DTIL) After Its Latest Results - webull.com
Precision BioSciences (NASDAQ:DTIL) Announces Quarterly Earnings Results - MarketBeat
Precision BioSciences (NASDAQ:DTIL) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
Precision BioSciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plansmoomoo - Moomoo
Precision Trading with Precision Biosciences Inc. (DTIL) Risk Zones - Stock Traders Daily
Precision BioSciences, Inc. (DTIL) stock price, news, quote and history - Yahoo Finance Singapore
DTIL Looks 315.0% Overvalued on GF Value™ - GuruFocus
Form 8K Precision BioSciences Inc For: 6 August By Investing.com - Investing.com Nigeria
Precision BioSciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Precision BioSciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Precision BioSciences Q2 net loss widens on warrant liability charge - TradingView
Precision BioSciences reports Q2 2026 net loss $32.7M; $112.4M cash supports runway through 2028 - TradingView
PRECISION BIOSCIENCES INC Q2 2026: Revenue $0 EPS $(1.26) — 10-Q Summary - tradingview.com
Precision BioSciences (NASDAQ: DTIL) books $10.8M H1 revenue and advances gene editing trials - Stock Titan
Precision Biosciences 2Q Loss/Shr $1.26 >DTIL - moomoo.com
Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update - Yahoo Finance
Q2 EPS Forecast for Precision BioSciences Lowered by Analyst - MarketBeat
Revenue Downgrade: Here's What Analysts Forecast For Precision BioSciences, Inc. (NASDAQ:DTIL) - webull.com
Precision BioSciences Inc expected to post a loss of 79 cents a shareEarnings Preview - TradingView
Analysts Offer Insights on Healthcare Companies: Precigen (PGEN) and Precision BioSciences (DTIL) - The Globe and Mail
Precision BioSciences (DTIL) Climbs 3.12% to $7.28 as Gene-Editing Support HoldsRegression Channel - vinanet.vn
H.C. Wainwright reiterates Precision BioSciences stock rating at buy By Investing.com - Investing.com Nigeria
H.C. Wainwright reiterates Precision BioSciences stock rating at buy - Investing.com
Weekly Recap: Q2 2026 report date confirmed and COO and CFO appointments - TradingView
Precision Biosciences (DTIL) officer details stock and RSU holdings - Stock Titan
Precision Biosciences Inc Azioni (DTIL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):